Under construction – not a live service
Sign in
Taking people in ChinaNo phase

Studies how generalized epilepsy syndromes appear and progress over time

Observes people with idiopathic generalized epilepsy to describe symptoms, brain tests and long-term course.

Plain-language title generated from the registry record
Registry title: Idiopathic Generalized Epilepsy Syndromes

Key facts

Where
Hangzhou, ChinaSee the site

Could this be for you?

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 4 and 40 years old?

Source: NCT06388174, who can take part

Where in China

  • 2nd Affiliated Hospital, School of Medicine, Zhejiang University, ChinaHangzhou, ChinaTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
Shen Chun-Hong
Trial code
NCT06388174
Record updated
27 August 2025
Original description
The idiopathic generalized epilepsies (IGEs) have historically included the syndromes childhood absence epilepsy (CAE), juvenile absence epilepsy (JAE), juvenile myoclonic epilepsy (JME), and epilepsy with generalized tonic-clonic seizures alone (GTCA). Recognition of the IGEs is important for clinical care, as it informs diagnosis, prevents unnecessary investigation, allows optimal selection of anti-seizure medications (ASMs), and provides prognostic guidance.Read full original descriptionShow less

Idiopathic Generalized Epilepsy Syndromes: Clinical Features and Long-term Outcomes

The idiopathic generalized epilepsies (IGEs) have historically included the syndromes childhood absence epilepsy (CAE), juvenile absence epilepsy (JAE), juvenile myoclonic epilepsy (JME), and epilepsy with generalized tonic-clonic seizures alone (GTCA). Recognition of the IGEs is important for clinical care, as it informs diagnosis, prevents unnecessary investigation, allows optimal selection of anti-seizure medications (ASMs), and provides prognostic guidance.

According to the new ILAE definition in 2022, the study aims to describe the clinical features, electroencephalographic, imaging findings and long-term prognosis.

Inclusion: Patients are consecutively and prospectively enrolled from epilepsy center, with newly diagnosed epilepsy or established epilepsy; Patients have a diagnosis of idiopathic generalized epilepsy (IGE), according to the 2022 diagnostic criteria; Comprehensive clinical information is collected, and 24 hour video-electroencephalography is performed; Sign the informed consent forms.

Exclusion: Other epilepsy syndromes are considered during follow-up, such as genetic generalized epilepsy; Lost to follow-up.

ClinicalTrials.gov NCT06388174